AI for Pharma Growth
E200: Podcast with Cures & Capital Part 3
AI for Pharma Growth
•January 14, 2026•29 min
0
AI for Pharma Growth•Jan 14, 2026
Key Takeaways
- •AI speeds regulatory submissions up to 40% with low risk.
- •AI-discovered drugs expected to dominate market within five years.
- •Digital twins could replace human clinical trials in a decade.
- •Human‑in‑the‑loop trust essential for successful pharma AI adoption.
- •New roles like algorithmic biologists will reshape pharma operating models.
Pulse Analysis
Pharma leaders can capture immediate value by deploying generative AI in regulatory, clinical documentation, and medical affairs. Off‑the‑shelf tools already cut submission timelines by roughly 40% and slash costs up to 50%, all without heavy IT infrastructure. These quick‑win projects rely on public literature and guideline data, keeping risk low while augmenting, not replacing, human expertise.\n\nLooking ahead, AI is set to overhaul the entire drug development pipeline. Within five years, a majority of new molecules will be discovered by algorithms, and fully AI‑designed compounds are nearing market approval. The rise of digital twins promises to simulate human physiology, potentially eliminating traditional clinical trials, while 3D‑printed, patient‑specific medicines could become routine. This shift also nudges the industry toward prevention, as AI can flag cancers from a single blood draw with near‑clinical accuracy.\n\nSuccess, however, hinges on people, not just technology. Trust, change management, and a clear human‑in‑the‑loop framework are essential to avoid the pitfalls seen in early AI deployments. Regulators like the FDA are drafting clearer guidelines, encouraging proactive engagement. New career tracks—AI‑human interface specialists, algorithmic biologists, and data‑driven strategists—will emerge as companies move from siloed pilots to integrated, ecosystem‑wide AI strategies, turning technology into a sustainable competitive advantage.
Episode Description
In this episode, Dr. Andre Bates, Founder & CEO of Eularis, joins Cures and Capital hosts Martin and Simona to explore how artificial intelligence is transforming drug discovery, R&D productivity, and enterprise strategy across the biopharma industry.
Dr. Andre Bates shares a pragmatic view on AI in the biopharma industry, cutting through the hype to explore where AI is already delivering value and where companies need to focus for real impact. From regulatory document preparation to AI-driven drug discovery, Andre explains how AI is transforming the industry—and why human adoption is just as critical as the technology itself.
What You’ll Learn from This Episode:
The “low-hanging fruit” for AI in pharma, including regulatory, clinical, and medical affairs applications.
How AI is accelerating drug discovery, clinical trials, and predictive healthcare.
The importance of human trust and adoption in successful AI implementation.
Predictions for AI-driven transformations in business models, digital twins, and disease prevention.
Practical steps for building a disciplined AI strategy with measurable ROI.
About the Podcast
AI for Pharma Growth is a podcast focused on exploring how artificial intelligence can revolutionise healthcare by addressing disparities and creating equitable systems. Join us as we unpack groundbreaking technologies, real-world applications, and expert insights to inspire a healthier, more equitable future.
This show brings together leading experts and changemakers to demystify AI and show how it’s being used to transform healthcare. Whether you're in the medical field, technology sector, or just curious about AI’s role in social good, this podcast offers valuable insights.
AI For Pharma Growth is the podcast from pioneering Pharma Artificial Intelligence entrepreneur Dr. Andree Bates created to help organisations understand how the use of AI based technologies can easily save them time and grow their brands and business. This show blends deep experience in the sector with demystifying AI for all pharma people, from start up biotech right through to Big Pharma. In this podcast Dr Andree will teach you the tried and true secrets to building a pharma company using AI that anyone can use, at any budget.
As the author of many peer-reviewed journals and having addressed over 500 industry conferences across the globe, Dr Andree Bates uses her obsession with all things AI and futuretech to help you to navigate through the, sometimes confusing but, magical world of AI powered tools to grow pharma businesses.
This podcast features many experts who have developed powerful AI powered tools that are the secret behind some time saving and supercharged revenue generating business results. Those who share their stories and expertise show how AI can be applied to sales, marketing, production, social media, psychology, customer insights and so much more.
Dr. Andree Bates LinkedIn | Facebook | Twitter
Show Notes
0
Comments
Want to join the conversation?
Loading comments...